We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

130 hedge funds and large institutions have $179M invested in Anika Therapeutics in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 41 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,133% more call options, than puts

Call options by funds: $277K | Put options by funds: $3K

52% more capital invested

Capital invested by funds: $118M → $179M (+$61.3M)

41% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 17

20% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 41

7.23% more ownership

Funds ownership: 85% → 92.22% (+7.2%)

3% more funds holding

Funds holding: 126 → 130 (+4)

Holders
130
Holders Change
+4
Holders Change %
+3.17%
% of All Funds
1.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
49
Reduced
41
Closed
17
Calls
$277K
Puts
$3K
Net Calls
+$274K
Net Calls Change
+$240K

Top Buyers

1
Deutsche Bank
Deutsche Bank
Germany
+$3.16M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$2.36M
3
UBS Group
UBS Group
Switzerland
+$1.21M
4
Morgan Stanley
Morgan Stanley
New York
+$1.16M
5
JFG
Jefferies Financial Group
New York
+$1.09M

Top Sellers

1
TI
Trigran Investments
Illinois
-$1.62M
2
GCP
GSA Capital Partners
United Kingdom
-$1.17M
3
Jane Street
Jane Street
New York
-$933K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$791K
5
Marshall Wace
Marshall Wace
United Kingdom
-$734K
Name Holding Trade Value Shares
Change 		Change in
Stake
JFG
26
Jefferies Financial Group
New York
$1.36M +$1.09M +93,500 New
VFT
27
Vanguard Fiduciary Trust
Pennsylvania
$1.31M +$1.05M +90,374 New
GC
28
Globeflex Capital
California
$1.27M – – –
Massachusetts Financial Services
29
Massachusetts Financial Services
Massachusetts
$1.08M +$328K +28,241 +61%
VPM
30
Vanguard Portfolio Management
Pennsylvania
$1.05M +$838K +72,160 New
IIM
31
Ironwood Investment Management
Massachusetts
$951K -$499 -43 -0.1%
TI
32
Trexquant Investment
Connecticut
$929K -$502K -43,254 -40%
EGM
33
Engineers Gate Manager
New York
$853K +$215K +18,552 +46%
Jane Street
34
Jane Street
New York
$789K -$933K -80,344 -60%
DM
35
Diker Management
New York
$778K -$52.8K -4,548 -8%
Barclays
36
Barclays
United Kingdom
$767K -$204K -17,578 -25%
Ameriprise
37
Ameriprise
Minnesota
$757K -$11.6K -1,003 -2%
Citadel Advisors
38
Citadel Advisors
Florida
$755K +$58K +4,996 +11%
HSBC Holdings
39
HSBC Holdings
United Kingdom
$729K +$22.6K +1,951 +4%
RS
40
R Squared
Hong Kong
$728K +$99.9K +8,603 +21%
AIM
41
Advyzon Investment Management
Illinois
$723K +$18.1K +1,559 +3%
IP
42
Indivisible Partners
Florida
$721K -$7.49K -645 -1%
Fidelity Investments
43
Fidelity Investments
Massachusetts
$698K +$173K +14,913 +45%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$685K -$290K -24,960 -35%
Assenagon Asset Management
45
Assenagon Asset Management
Luxembourg
$675K +$394K +33,951 +269%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$663K -$44.9K -3,867 -8%
Bank of New York Mellon
47
Bank of New York Mellon
New York
$577K -$8.57K -738 -2%
XT
48
XTX Topco
Cayman Islands
$574K +$201K +17,344 +78%
PWM
49
Palumbo Wealth Management
New York
$572K +$458K +39,426 New
Bank of America
50
Bank of America
North Carolina
$539K -$129K -11,124 -23%
1
2
3 4 5

ANIK Hedge Fund Activity: Q1 2026 in Review

130 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q1 2026, worth a combined $179M — up 52% from $118M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ANIK positions and 17 closed out — a net gain of 7 holders — while 49 added to existing stakes and 41 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $3.16M. The largest seller was Trigran Investments, exiting entirely with an estimated $1.62M sold.

  • 130 institutional investors held Anika Therapeutics (ANIK) as of Q1 2026, up from 126 in Q4 2025.
  • Funds reported $179M of Anika Therapeutics stock for Q1 2026, up 52% quarter-over-quarter.
  • 24 funds opened new Anika Therapeutics positions in Q1 2026 and 17 closed out, a net change of +7 holders.
  • The largest Anika Therapeutics buyer in Q1 2026 was Deutsche Bank, an estimated $3.16M added.
  • The largest Anika Therapeutics seller in Q1 2026 was Trigran Investments, an estimated $1.62M sold.

Based on aggregated 13F filings for Q1 2026.